Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 79 articles:
HTML format



Single Articles


    August 2022
  1. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available


    July 2022
  2. YAMAZAKI K, Ishida Y, Sasaki S, Toyama Y, et al
    Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    J Cardiol. 2022 Jul 25. pii: S0914-5087(22)00160.
    PubMed     Abstract available


    June 2022
  3. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306].
    J Cardiol. 2022 Jun 29. pii: S0914-5087(22)00154.
    PubMed    


  4. HEMMI H, Kataoka N, Imamura T
    Paroxysmal atrial fibrillation as a cause of unexplained syncope.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00139.
    PubMed    


  5. YAMASHITA T, Uchiyama S, Atarashi H, Okumura K, et al
    Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.
    J Cardiol. 2022 Jun 15. pii: S0914-5087(22)00096.
    PubMed     Abstract available


  6. FUKUNAGA M, Isotani A, Shirai S, Murakami N, et al
    Initial practice of left atrial appendage closure device in Japan; single-center experience.
    J Cardiol. 2022;79:752-758.
    PubMed     Abstract available


    April 2022
  7. VARNEY JA, Dong VS, Tsao T, Sabir MS, et al
    COVID-19 and arrhythmia: An overview.
    J Cardiol. 2022;79:468-475.
    PubMed     Abstract available


  8. KUNO T, Takahashi M, So M, Egorova NN, et al
    The association of anticoagulation before admission and survival of patients with COVID-19.
    J Cardiol. 2022;79:489-493.
    PubMed     Abstract available


    March 2022
  9. MIYAZAKI S, Miyauchi K, Hayashi H, Yamashiro K, et al
    Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    J Cardiol. 2022 Mar 25. pii: S0914-5087(22)00058.
    PubMed     Abstract available


  10. CHEN WT, Lo LW, Tsai WC, Lin YJ, et al
    Application of dynamic display technology to identify gaps after pulmonary vein isolation in catheter ablation of atrial fibrillation.
    J Cardiol. 2022 Mar 23. pii: S0914-5087(22)00052.
    PubMed     Abstract available


  11. MIYAZAKI Y, Yamagata K, Ishibashi K, Inoue Y, et al
    Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
    J Cardiol. 2022 Mar 12. pii: S0914-5087(22)00049.
    PubMed     Abstract available


  12. OGURA S, Nakamura K, Morita H, Nakagawa K, et al
    Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    J Cardiol. 2022;79:446-452.
    PubMed     Abstract available


    February 2022
  13. YAMANE T
    Catheter ablation of atrial fibrillation: Current status and near future.
    J Cardiol. 2022 Feb 24. pii: S0914-5087(22)00025.
    PubMed     Abstract available


  14. MORI H, Fukui K, Maeda A, Akashi Y, et al
    Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00029.
    PubMed     Abstract available


  15. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available


  16. OUCHI K, Sakuma T, Higuchi T, Yoshida J, et al
    Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
    J Cardiol. 2022;79:211-218.
    PubMed     Abstract available


  17. NAKAJIMA Y
    Effectiveness and safety of transcatheter left atrial appendage closure.
    J Cardiol. 2022;79:186-193.
    PubMed     Abstract available


    January 2022
  18. CHEN JY, Chen TW, Lu WD
    The HAT2CH2 score predicts neurologic events in patients with cardiac implantable electronic devices without atrial fibrillation.
    J Cardiol. 2022 Jan 8. pii: S0914-5087(21)00385.
    PubMed     Abstract available


  19. MIYAZAKI A, Uemura H
    Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch.
    J Cardiol. 2022;79:30-35.
    PubMed     Abstract available


    December 2021
  20. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    PubMed     Abstract available


  21. KURAOKA A, Ishizu T, Sato M, Igarashi M, et al
    Left atrial regional strain assessed by novel dedicated three-dimensional speckle tracking echocardiography.
    J Cardiol. 2021;78:517-523.
    PubMed     Abstract available


    November 2021
  22. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    PubMed     Abstract available


  23. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    PubMed     Abstract available


  24. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available


  25. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    PubMed     Abstract available


    October 2021
  26. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    PubMed     Abstract available


  27. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    PubMed     Abstract available


  28. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    PubMed     Abstract available


  29. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    PubMed     Abstract available


  30. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    PubMed     Abstract available


  31. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    


    September 2021
  32. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available


  33. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available


    August 2021
  34. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available


  35. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    PubMed     Abstract available


    July 2021
  36. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    PubMed     Abstract available


  37. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.
    PubMed    


  38. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed     Abstract available


    June 2021
  39. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    PubMed     Abstract available


  40. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    PubMed     Abstract available


  41. IMAMURA T
    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.
    PubMed    


  42. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    PubMed     Abstract available


  43. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    PubMed     Abstract available


  44. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available


  45. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed     Abstract available


    May 2021
  46. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available


    April 2021
  47. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available


  48. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed     Abstract available


  49. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available


  50. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed     Abstract available


    March 2021
  51. YAGI N, Suzuki S, Nagai K, Tanaka T, et al
    Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis.
    J Cardiol. 2021 Mar 2. pii: S0914-5087(21)00043.
    PubMed     Abstract available


  52. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed     Abstract available


    February 2021
  53. SHINOHARA M, Wada R, Yano K, Akitsu K, et al
    Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants.
    J Cardiol. 2021;77:147-153.
    PubMed     Abstract available


  54. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    PubMed     Abstract available


  55. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
    Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
    J Cardiol. 2021;77:195-200.
    PubMed     Abstract available


  56. CHEN JY, Lu WD
    Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
    J Cardiol. 2021;77:166-173.
    PubMed     Abstract available


    January 2021
  57. KIMATA A, Nogami A, Yamasaki H, Ohigashi T, et al
    Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials.
    J Cardiol. 2021 Jan 25. pii: S0914-5087(20)30414.
    PubMed     Abstract available


  58. YAGI N, Itoh H, Hisamatsu T, Tomita Y, et al
    Corrigendum to "A challenge for mutation specific risk stratification in long QT syndrome type 1" [J. Cardiol. 72(1) (2018) 56-65].
    J Cardiol. 2021 Jan 1. pii: S0914-5087(20)30313.
    PubMed    


    November 2020
  59. OKADA M, Tanaka N, Oka T, Tanaka K, et al
    Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction.
    J Cardiol. 2020 Nov 30. pii: S0914-5087(20)30368.
    PubMed     Abstract available


  60. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available


  61. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available


    September 2020
  62. NAKAMURA M, Yamashita T, Hayakawa A, Matsumoto T, et al
    Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
    J Cardiol. 2020 Sep 14. pii: S0914-5087(20)30293.
    PubMed     Abstract available


  63. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.
    PubMed    


    August 2020
  64. MEHRAN R, Vogel B, Levy P
    Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
    J Cardiol. 2020 Aug 26. pii: S0914-5087(20)30258.
    PubMed     Abstract available


  65. TANAKA Y, Tada H, Hara S, Hayashi K, et al
    Association of proteinuria with incident atrial fibrillation in the general Japanese population.
    J Cardiol. 2020 Aug 23. pii: S0914-5087(20)30277.
    PubMed     Abstract available


  66. KOSIUK J, Langenhan K, Hindricks G, Bollmann A, et al
    Remote ischemic preconditioning in a setting of electrical cardioversion of early onset persistent atrial fibrillation (RIP CAF trial): Rationale and study design.
    J Cardiol. 2020 Aug 23. pii: S0914-5087(20)30272.
    PubMed     Abstract available


  67. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available


  68. KOSHIYAMA M, Tamaki K, Ohsawa M
    Age-specific incidence rates of atrial fibrillation and risk factors for the future development of atrial fibrillation in the Japanese general population.
    J Cardiol. 2020 Aug 13. pii: S0914-5087(20)30263.
    PubMed     Abstract available


  69. NISHIMURA S, Izumi C, Yamasaki S, Obayashi Y, et al
    Impact of right ventricular function on development of significant tricuspid regurgitation in patients with chronic atrial fibrillation.
    J Cardiol. 2020 Aug 3. pii: S0914-5087(20)30152.
    PubMed     Abstract available


    July 2020
  70. MIYAZAKI A, Negishi J, Hayama Y, Tsuda E, et al
    Etiology of atrial fibrillation in patients with complex congenital heart disease - for a better treatment strategy.
    J Cardiol. 2020 Jul 20. pii: S0914-5087(20)30192.
    PubMed     Abstract available


  71. OKAWA K, Miyoshi T, Sogo M, Hara S, et al
    Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30224.
    PubMed     Abstract available


  72. CAFFREY JL, Wu CK, Chang CH, Lin JW, et al
    Analysis of mortality risk following receipt of implantable cardioverter defibrillators in patients with and without heart failure.
    J Cardiol. 2020 Jul 15. pii: S0914-5087(20)30184.
    PubMed     Abstract available


  73. PHAM VT, Lin C, Tran TT, M Su MY, et al
    Predicting ventricular tachyarrhythmia in patients with systolic heart failure based on texture features of the gray zone from contrast-enhanced magnetic resonance imaging.
    J Cardiol. 2020 Jul 13. pii: S0914-5087(20)30222.
    PubMed     Abstract available


  74. LIU SH, Lo LW, Tsai TY, Cheng WH, et al
    Circadian rhythm dynamics on multiscale entropy identifies autonomic dysfunction associated with risk of ventricular arrhythmias and near syncope in chronic kidney disease.
    J Cardiol. 2020 Jul 3. pii: S0914-5087(20)30179.
    PubMed     Abstract available


  75. OKUMURA K, Yamashita T, Akao M, Atarashi H, et al
    Characteristics and anticoagulant treatment status of elderly non-valvular atrial fibrillation patients with a history of catheter ablation in Japan: Subanalysis of the ANAFIE registry.
    J Cardiol. 2020 Jul 2. pii: S0914-5087(20)30209.
    PubMed     Abstract available


    May 2020
  76. KAWAKAMI S, Yasuda S, Ogawa H
    Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    J Cardiol. 2020 May 7. pii: S0914-5087(20)30091.
    PubMed     Abstract available


  77. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
    The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
    J Cardiol. 2020;75:567-570.
    PubMed     Abstract available


    April 2020
  78. SPARTALIS M, Iliopoulos DC, Spartalis E, Athanasiou A, et al
    The genesis of ventricular arrhythmias in heart failure patients is based on alterations in cardiac mechanical, morphological, metabolic, electrophysiological properties, and neurohumoral remodeling.
    J Cardiol. 2020 Apr 22. pii: S0914-5087(20)30104.
    PubMed    


  79. IZUMI C
    Isolated functional tricuspid regurgitation: When should we go to surgical treatment?
    J Cardiol. 2020;75:339-343.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: